Female Hormone And Fertility Panel

What this test measures

Comprehensive panels build on the core reproductive markers to include additional hormones and binding proteins. Depending on the laboratory, the list may add progesterone, prolactin, thyroid markers, total and free testosterone, DHEA sulfate, sex hormone-binding globulin, or anti-Mullerian hormone. The expanded set gives a provider more context when symptoms or questions are complex.

The panel uses serum samples collected from a vein, and collection timing follows the same considerations as basic hormone testing: cycle day for menstruating women and often morning for other markers. Because marker lists differ between laboratories, the order confirmation shows exactly which tests are included.

People may order this type of panel when a basic evaluation leaves questions open, during a fertility workup, when polycystic ovary syndrome or perimenopause is being considered, or when monitoring hormone therapy. More markers do not automatically mean clearer answers, so a qualified healthcare provider should interpret the panel as a whole with your symptoms and history.

• Estradiol
• Follicle-stimulating hormone (FSH)
• Luteinizing hormone (LH)
• Progesterone
• Prolactin
• Total and free testosterone (when included)
• DHEA sulfate (when included)
• Sex hormone-binding globulin (when included)
• Thyroid-stimulating hormone (when included)
• Anti-Mullerian hormone (when included)

Why people order this test

• Expanded evaluation of reproductive hormones
• Support a fertility workup
• Investigate polycystic ovary syndrome concerns
• Review perimenopause-related symptoms
• Monitor hormone therapy with a provider
• Follow up when a basic panel leaves questions

How to prepare

Timing may matter: a provider may specify a particular cycle day for collection, and morning collection is often suggested. Fasting is not usually required. A blood sample is collected from a vein. Follow the instructions provided with your order.

Understanding your results

Results are generally available within 1-3 business days. Reference ranges vary by age, cycle phase, and the assay used, and the panel is interpreted as a whole. A qualified healthcare provider should explain what the combined findings suggest and whether further evaluation is needed.